Derived from MYC-driven primary MB tumors, it is presently regarded as a cell system at the crossroad between G3 and G4 MB, reflecting in vitro the partial overlap observed between these tumor subgroups in vivo [32]. This evidence concerns the gene MYC and neoplasm.